医学
呼吸道
免疫学
炎症
发病机制
单克隆抗体
呼吸上皮
促炎细胞因子
呼吸系统
呼吸道疾病
慢性阻塞性肺病
肺
疾病
细胞因子
嗜酸性
呼吸道感染
哮喘
气道
抗体
白细胞介素
单克隆
免疫系统
作者
E.D. Timotievich,Igor Petrovich Shilovskiy,Danila A. Gurskii,Anatoli D. Taganovich,Aleksei G. Kadushkin,Musa Khaitov
出处
期刊:Biokhimiya
[Pleiades Publishing]
日期:2026-01-01
卷期号:91 (1): 17-38
被引量:2
标识
DOI:10.1134/s0006297925602655
摘要
In recent years, understanding of the key role of epithelial cytokines (IL-25, IL-33, and TSLP) in the development of respiratory tract inflammatory diseases has significantly expanded. These molecules, released by airway epithelium in response to allergens, pathogens, and damaging agents, act as alarmins, initiating a cascade of the Th2-mediated inflammation that leads to the IgE-mediated reactions, eosinophilic infiltration, and tissue remodeling. Beyond classical allergic processes, epithelial cytokines play a crucial role in the virus-induced exacerbations of respiratory diseases and pathogenesis of chronic obstructive pulmonary disease (COPD). Monoclonal antibody therapeutics targeting these cytokines have demonstrated efficacy in treating severe asthma. This review summarizes current data on contribution of TSLP, IL-33, and IL-25 to the respiratory tract inflammation and discusses the prospects of their targeted inhibition to improve therapeutic efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI